First Quadrant’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-71
| Closed | -$22K | – | 540 |
|
2021
Q4 | $22K | Buy |
+71
| New | +$22K | ﹤0.01% | 467 |
|
2019
Q4 | – | Sell |
-380
| Closed | -$104K | – | 623 |
|
2019
Q3 | $104K | Sell |
380
-341
| -47% | -$93.3K | 0.01% | 482 |
|
2019
Q2 | $271K | Sell |
721
-378
| -34% | -$142K | 0.02% | 480 |
|
2019
Q1 | $294K | Sell |
1,099
-866
| -44% | -$232K | 0.02% | 440 |
|
2018
Q4 | $418K | Hold |
1,965
| – | – | 0.03% | 391 |
|
2018
Q3 | $880K | Sell |
1,965
-1,135
| -37% | -$508K | 0.02% | 400 |
|
2018
Q2 | $1.26M | Sell |
3,100
-30
| -1% | -$12.2K | 0.02% | 381 |
|
2018
Q1 | $1.71M | Buy |
3,130
+2,020
| +182% | +$1.1M | 0.03% | 337 |
|
2017
Q4 | $670K | Buy |
1,110
+84
| +8% | +$50.7K | 0.01% | 498 |
|
2017
Q3 | $473K | Buy |
+1,026
| New | +$473K | 0.01% | 561 |
|